Kenneth Bahrt Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kenneth Bahrt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kenneth Bahrt. Kenneth Bahrt is SVP, Chief Medical Officer in SAVIENT PHARMACEUTICALS INC ($SVNT) and Chief Medical Officer in Oncobiologics, Inc. ($ONS).
Latest Insider Trading Transactions of Kenneth Bahrt
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2019 | ONS | Outlook Therapeuti ... | Bahrt Kenneth | Chief Medical Offic ... | Option Exercise | A | 1.32 | 600,000 | 792,000 | 600,000 | |
Oct 24 2018 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Option Exercise | A | 0.90 | 450,000 | 405,000 | 450,000 | |
Jun 27 2018 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Sell | S | 0.85 | 7,700 | 6,507 | 47,120 | 54.8 K to 47.1 K (-14.05 %) |
Dec 26 2017 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Buy | S | 1.13 | 26,165 | 29,566 | 54,820 | 28.7 K to 54.8 K (+91.31 %) |
Dec 22 2016 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Grant | A | 0.00 | 50,000 | 0 | 80,985 | 31 K to 81 K (+161.37 %) |
May 17 2016 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Option Exercise | P | 8.50 | 1,000 | 8,500 | 1,000 | |
May 17 2016 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Option Exercise | P | 6.60 | 1,000 | 6,600 | 1,000 | |
May 17 2016 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Buy | P | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Aug 03 2012 | SVNT | SAVIENT PHARMACEUT ... | Bahrt Kenneth | SVP, Chief Medical ... | Sell | S | 0.62 | 4,950 | 3,069 | 203,050 | 208 K to 203.1 K (-2.38 %) |
Feb 13 2012 | SVNT | SAVIENT PHARMACEUT ... | Bahrt Kenneth | SVP, Chief Medical ... | Option Exercise | A | 2.26 | 100,000 | 226,000 | 100,000 | |
Feb 13 2012 | SVNT | SAVIENT PHARMACEUT ... | Bahrt Kenneth | SVP, Chief Medical ... | Grant | A | 2.26 | 150,000 | 339,000 | 208,000 | 58 K to 208 K (+258.62 %) |
Nov 18 2011 | SVNT | SAVIENT PHARMACEUT ... | Bahrt Kenneth | SVP, Chief Medical ... | Buy | P | 2.59 | 5,000 | 12,945 | 58,000 | 53 K to 58 K (+9.43 %) |
Sep 16 2011 | SVNT | SAVIENT PHARMACEUT ... | Bahrt Kenneth | SVP, Chief Medical ... | Buy | P | 3.97 | 500 | 1,983 | 53,000 | 52.5 K to 53 K (+0.95 %) |
Sep 16 2011 | SVNT | SAVIENT PHARMACEUT ... | Bahrt Kenneth | SVP, Chief Medical ... | Buy | P | 3.95 | 2,500 | 9,871 | 52,500 | 50 K to 52.5 K (+5.00 %) |
Aug 02 2011 | SVNT | SAVIENT PHARMACEUT ... | Bahrt Kenneth | SVP, Chief Medical ... | Option Exercise | A | 7.00 | 150,000 | 1,050,000 | 150,000 | |
Aug 02 2011 | SVNT | SAVIENT PHARMACEUT ... | Bahrt Kenneth | SVP, Chief Medical ... | Grant | A | 7.00 | 50,000 | 350,000 | 50,000 | 100 K to 50 K (-50.00 %) |
Page: 1